Cyclosporin A Market

It is suitable for the prevention of rejection in allograft transplantation of kidney, liver, heart, bone marrow and other organs or tissues.Prevention and treatment of graft versus host reaction in bone marrow transplantation.This product is often used in combination with immunosuppressive agents such as adrenocorticosteroids to improve the efficacy.In recent years, it has been reported to be used in the treatment of ocular pigmentosis, severe aplastic anemia, refractory autoimmune thrombocytopenic purpura, psoriasis, refractory lupus nephritis, etc.

Cyclosporin A Market contains market size and forecasts of Cyclosporin A (Cyclosporin) in Global, including the following market information:

Global Cyclosporin A (Cyclosporin) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Cyclosporin A (Cyclosporin) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

by Drug Nature Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cyclosporin A (Cyclosporin) include Novartis, Dexcel Pharma, Santen, Daiichi Sankyo, TBG Diagnostics, Teva, Affitech, Abbott and Sanofi, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Cyclosporin A (Cyclosporin) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cyclosporin A (Cyclosporin) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Cyclosporin A (Cyclosporin) Market Segment Percentages, by Type, 2021 (%)

by Drug Nature

Chemical Drugs

Natural Products

Biological Drugs

by Dosage Form

Injection

Solution

Capsule

Global Cyclosporin A (Cyclosporin) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Cyclosporin A (Cyclosporin) Market Segment Percentages, by Application, 2021 (%)

Immune Diseases

Arthritis

Myasthenia Gravis

Graft Rejection

Eczema

Ophthalmochromatosis

Nephrotic Syndrome

Anemia

Other

Global Cyclosporin A (Cyclosporin) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Cyclosporin A (Cyclosporin) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Cyclosporin A (Cyclosporin) revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Cyclosporin A (Cyclosporin) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Novartis

Dexcel Pharma

Santen

Daiichi Sankyo

TBG Diagnostics

Teva

Affitech

Abbott

Sanofi

AbbVie

Apidel

PARI Pharma

Auven Therapeutics

Nanomerics

Novaliq

Ascendia Pharma

Abliva AB

Taejoon Pharm

Perle Bioscience

Zosano Pharma

Sublimity Therapeutics

Sinopharm

Livzon

Beijing SL Pharmaceutical

Tianjin Central Pharmaceutical

Wuxi Shuhui Pharmaceutical

Huadong Medicine

SkyePharma

Vectura Group

Sarepta Therapeutics

SkyePharma

Vectura Group

Sarepta Therapeutics

Poli

Jubilant Life Sciences

Gilead